Glutamate release by primary brain tumors induces epileptic activity
Switon K, Kotulska K, Janusz-Kaminska A, Zmorzynska J, Jaworski J
Michelle Oravitz: Right
This rigorous screening ensures that only clinically appropriate candidates are selected for our advanced cellular therapy programs for insomnia [21-25]
However, MPT inhibitors do not stop NAPQI generation or GSH depletion ( The permeabilization of the MOM due to MPT releases apoptogenic proteins such as cytochrome c, second mitochondria-derived activator of caspase (Smac), apoptosis inducing factor (AIF), and endonuclease G from the intermembrane space
TABLE 2 summarizes the dosing, common and serious side effects, and major precautions for current pharmacologic treatment options